En-tête de navigationNavigation principaleSuiviFiche


Unité de recherche
PCRD EU
Numéro de projet
00.0219
Titre du projet
LENTIVIRAL VECTORS: Lentiviral vectors for gene therapy of the hematopoietic system: developement from bench to bedside
Titre du projet anglais
LENTIVIRAL VECTORS: Lentiviral vectors for gene therapy of the hematopoietic system: developement from bench to bedside

Textes relatifs à ce projet

 AllemandFrançaisItalienAnglais
Mots-clé
-
-
-
Anzeigen
Autre Numéro de projet
-
-
-
Anzeigen
Programme de recherche
-
-
-
Anzeigen
Description succincte
-
-
-
Anzeigen
Autres indications
-
-
-
Anzeigen
Partenaires et organisations internationales
-
-
-
Anzeigen
Résumé des résultats (Abstract)
-
-
-
Anzeigen
Références bases de données
-
-
-
Anzeigen

Textes saisis


CatégorieTexte
Mots-clé
(Anglais)
Gene therapy; stem cells; blood disorders; lentiviral vectors;
Biotechnology; Environmental Protection; Innovation; Technology Transfer; Life Sciences; Medicine; Health; Waste Management
Autre Numéro de projet
(Anglais)
EU project number: h QLK3-1999-00859
Programme de recherche
(Anglais)
EU-programme: 5. Frame Research Programme - 1.1.3 The 'cell factory'
Description succincte
(Anglais)
See abstract
Autres indications
(Anglais)
Full name of research-institution/enterprise:
Université de Genève
Département de Génétique et Microbiologie
CMU
Partenaires et organisations internationales
(Anglais)
Coordinator: Unicesità degli Studi di Torino (I)
Résumé des résultats (Abstract)
(Anglais)
Gene transfer into the hematopoietic system is a promising therapy for several inherited (immunodeficiencies, lysosomal storage disorders, hemophilias) or acquired human diseases (AIDS, cancer). Yet the genetic modification of human hematopoietic stem cells (HSC) to provide a lifelong supply of corrected progeny remain s the most daunting challenge to the success of this endeavor, because HSC are mostly quiescent and hence difficult to transduce. A major breakthrough has been obtained through the creation of lentiviral vectors, which can mediate the efficient integration and long-term expression of transgenes into nondividing cells, including HSC. This project aims at exploiting the tremendous potential of lenti viral vectors for gene transfer into HSC, in order to bring this new technology from bench to bedside for the therapy of human disease, and to exact its value f or the competitiveness of the EU biomedical industry.
Références bases de données
(Anglais)
Swiss Database: Euro-DB of the
State Secretariat for Education and Research
Hallwylstrasse 4
CH-3003 Berne, Switzerland
Tel. +41 31 322 74 82
Swiss Project-Number: 00.0219